Hemostemix Inc (HEM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.839x

Based on the latest financial reports, Hemostemix Inc (HEM) has a cash flow conversion efficiency ratio of 0.839x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-2.91 Million ≈ $-2.10 Million USD) by net assets (CA$-3.46 Million ≈ $-2.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see HEM market cap overview for the company's overall valuation and market capitalisation.

Hemostemix Inc - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Hemostemix Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hemostemix Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hemostemix Inc ranked by their cash flow conversion efficiency. See HEM cash flow to debt ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Yummy Town Cayman Holdings TWO:2726	0.002x
SaveLend Group AB ST:YIELD	0.019x
Ming Shing Group Holdings Ltd NASDAQ:MSW	-0.033x
Techcential International Ltd TWO:6616	0.038x
Adaptimmune Therapeutics Plc NASDAQ:ADAP	0.490x
Culpeo Minerals Ltd AU:CPO	-0.105x
Obm Drilchem PT JK:OBMD	0.006x
Duketon Mining Ltd AU:DKM	-0.008x

Annual Cash Flow Conversion Efficiency for Hemostemix Inc (2013–2024)

The table below shows the annual cash flow conversion efficiency of Hemostemix Inc from 2013 to 2024. View HEM live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$-7.20 Million ≈ $-5.21 Million	CA$-1.90 Million ≈ $-1.38 Million	0.264x	+29.94%
2023-12-31	CA$-7.37 Million ≈ $-5.33 Million	CA$-1.50 Million ≈ $-1.08 Million	0.203x	-77.46%
2022-12-31	CA$-6.77 Million ≈ $-4.90 Million	CA$-6.10 Million ≈ $-4.41 Million	0.901x	+36.96%
2021-12-31	CA$-5.28 Million ≈ $-3.82 Million	CA$-3.48 Million ≈ $-2.52 Million	0.658x	-87.90%
2020-12-31	CA$-1.10 Million ≈ $-794.78K	CA$-5.98 Million ≈ $-4.32 Million	5.438x	+546.31%
2019-12-31	CA$-4.05 Million ≈ $-2.93 Million	CA$-3.40 Million ≈ $-2.46 Million	0.841x	+115.26%
2018-12-31	CA$487.80K ≈ $352.87K	CA$-2.69 Million ≈ $-1.95 Million	-5.513x	-730.03%
2017-12-31	CA$4.84 Million ≈ $3.50 Million	CA$-3.21 Million ≈ $-2.32 Million	-0.664x	-185.48%
2016-12-31	CA$-3.46 Million ≈ $-2.50 Million	CA$-2.69 Million ≈ $-1.95 Million	0.777x	+103.82%
2015-12-31	CA$174.08K ≈ $125.93K	CA$-3.55 Million ≈ $-2.56 Million	-20.365x	-2102.29%
2014-12-31	CA$3.39 Million ≈ $2.45 Million	CA$-3.13 Million ≈ $-2.27 Million	-0.925x	+52.07%
2013-12-31	CA$573.87K ≈ $415.13K	CA$-1.11 Million ≈ $-800.95K	-1.929x	--

About Hemostemix Inc

V:HEM Canada Biotechnology

Market Cap

$9.54 Million

CA$13.19 Million CAD

Market Cap Rank

#27268 Global

#1134 in Canada

Share Price

CA$0.07

Change (1 day)

-6.67%

52-Week Range

CA$0.05 - CA$0.12

All Time High

CA$13.40